Related references
Note: Only part of the references are listed.SF3B1 mutations induce R-loop accumulation and DNA damage in MDS and leukemia cells with therapeutic implications
Shalini Singh et al.
LEUKEMIA (2020)
U1 snRNP regulates cancer cell migration and invasion in vitro
Jung-Min Oh et al.
NATURE COMMUNICATIONS (2020)
Design and Synthesis of 1,2-Deoxy-pyranose Derivatives of Spliceostatin A toward Prostate Cancer Treatment
Yusuke Yoshikawa et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Molecular architecture of the human 17S U2 snRNP
Zhenwei Zhang et al.
NATURE (2020)
Discovery of driver non-coding splice-site-creating mutations in cancer
Song Cao et al.
NATURE COMMUNICATIONS (2020)
Dysregulations of Functional RNA Modifications in Cancer, Cancer Stemness and Cancer Therapeutics
Mohammad Burhan Uddin et al.
THERANOSTICS (2020)
ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer
Laura Cato et al.
CANCER CELL (2019)
Small Nucleolar RNAs: Insight Into Their Function in Cancer
Junnan Liang et al.
FRONTIERS IN ONCOLOGY (2019)
RNA components of the spliceosome regulate tissue-and cancer-specific alternative splicing
Heidi Dvinge et al.
GENOME RESEARCH (2019)
A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS
Mary McMahon et al.
ELIFE (2019)
Spliceosomal disruption of the non-canonical BAF complex in cancer
Daichi Inoue et al.
NATURE (2019)
Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma
Hiromichi Suzuki et al.
NATURE (2019)
The U1 spliceosomal RNA is recurrently mutated in multiple cancers
Shimin Shuai et al.
NATURE (2019)
Design and synthesis of a phenyl C-glycoside derivative of Spliceostatin A and its biological evaluation toward prostate cancer treatment
Yusuke Yoshikawa et al.
TETRAHEDRON LETTERS (2019)
The cryo-EM structure of the SF3b spliceosome complex bound to a splicing modulator reveals a pre-mRNA substrate competitive mechanism of action
Lorenzo I. Finci et al.
GENES & DEVELOPMENT (2018)
The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor Mutations
Liang Chen et al.
MOLECULAR CELL (2018)
Structural Basis of Splicing Modulation by Antitumor Macrolide Compounds
Constantin Cretu et al.
MOLECULAR CELL (2018)
H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers
Michael Seiler et al.
NATURE MEDICINE (2018)
Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicing
Sarah Gerhart et al.
SCIENTIFIC REPORTS (2018)
Spliceosome Mutations Induce R Loop-Associated Sensitivity to ATR Inhibition in Myelodysplastic Syndromes
Hai Dang Nguyen et al.
CANCER RESEARCH (2018)
Guide snoRNAs: Drivers or Passengers in Human Disease?
Manisha Deogharia et al.
BIOLOGY-BASEL (2018)
Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis
Huairui Yuan et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Epigenetics at the base of alternative splicing changes that promote colorectal cancer
Alberto R. Kornblihtt
JOURNAL OF CLINICAL INVESTIGATION (2017)
Selective degradation of splicing factor CAPERα by anticancer sulfonamides
Taisuke Uehara et al.
NATURE CHEMICAL BIOLOGY (2017)
Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy
David R. Corey
NATURE NEUROSCIENCE (2017)
Dysregulation of spliceosome gene expression in advanced prostate cancer by RNA-binding protein PSF
Ken-ichi Takayama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15
Ting Han et al.
SCIENCE (2017)
Mutant U2AF1-expressing cells are sensitive to pharmacological modulation of the spliceosome
Cara Lunn Shirai et al.
NATURE COMMUNICATIONS (2017)
Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A-SF3b complex
Teng Teng et al.
NATURE COMMUNICATIONS (2017)
Development of Exon Skipping Therapies for Duchenne Muscular Dystrophy: A Critical Review and a Perspective on the Outstanding Issues
Annemieke Aartsma-Rus et al.
NUCLEIC ACID THERAPEUTICS (2017)
Emerging roles of hnRNPA1 in modulating malignant transformation
Rajat Roy et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2017)
Targeting a Single Alternative Polyadenylation Site Coordinately Blocks Expression of Androgen Receptor mRNA Splice Variants in Prostate Cancer
Jamie L. Van Etten et al.
CANCER RESEARCH (2017)
Cajal body function in genome organization and transcriptome diversity
Iain A. Sawyer et al.
BIOESSAYS (2016)
Physiologic Expression of Sf3b1K700E Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation
Esther A. Obeng et al.
CANCER CELL (2016)
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
Richard S. Finkel et al.
LANCET (2016)
Molecular Architecture of SF3b and Structural Consequences of Its Cancer-Related Mutations
Constantin Cretu et al.
MOLECULAR CELL (2016)
Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins
Stanley Chun-Wei Lee et al.
NATURE MEDICINE (2016)
Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage
Samar Alsafadi et al.
NATURE COMMUNICATIONS (2016)
Cajal bodies are linked to genome conformation
Qiuyan Wang et al.
NATURE COMMUNICATIONS (2016)
Synthetic Lethal Interactions of MDS-Associated Spliceosomal Gene Mutations Identifies the Basis for Their Mutual Exclusivity
Stanley Chun-Wei Lee et al.
BLOOD (2016)
SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition
Eunhee Kim et al.
CANCER CELL (2015)
Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo
Cara Lunn Shirai et al.
CANCER CELL (2015)
hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic Malignancies
Miguel Gallardo et al.
CANCER CELL (2015)
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
Elayne Chan-Penebre et al.
NATURE CHEMICAL BIOLOGY (2015)
Intron retention is a widespread mechanism of tumor-suppressor inactivation
Hyunchul Jung- et al.
NATURE GENETICS (2015)
The spliceosome assembly factor GEMIN2 attenuates the effects of temperature on alternative splicing and circadian rhythms
Ruben Gustavo Schlaen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities
Jian Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome
Vikas Madan et al.
NATURE COMMUNICATIONS (2015)
PRMT9 is a Type II methyltransferase that methylates the splicing factor SAP145
Yanzhong Yang et al.
NATURE COMMUNICATIONS (2015)
Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors
Garrett M. Frampton et al.
CANCER DISCOVERY (2015)
The RNA-binding protein Sam68 regulates expression and transcription function of the androgen receptor splice variant AR-V7
Jacqueline Stockley et al.
SCIENTIFIC REPORTS (2015)
Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch Point
Rachel B. Darman et al.
CELL REPORTS (2015)
Transcriptome Sequencing Reveals Potential Mechanism of Cryptic 3′ Splice Site Selection in SF3B1-mutated Cancers
Christopher DeBoever et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
U2AF1 mutations alter splice site recognition in hematological malignancies
Janine O. Ilagan et al.
GENOME RESEARCH (2015)
Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma
Fengting Yan et al.
CANCER RESEARCH (2014)
Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer
Chengfei Liu et al.
CLINICAL CANCER RESEARCH (2014)
Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia
Pedro G. Ferreira et al.
GENOME RESEARCH (2014)
Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition
Reem Ibrahim et al.
HUMAN PATHOLOGY (2014)
A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors
D. S. Hong et al.
INVESTIGATIONAL NEW DRUGS (2014)
Phosphoproteomics Screen Reveals Akt Isoform-Specific Signals Linking RNA Processing to Lung Cancer
Ioannis Sanidas et al.
MOLECULAR CELL (2014)
Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study
Thomas Voit et al.
LANCET NEUROLOGY (2014)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
Mechanisms for U2AF to define 3′ splice sites and regulate alternative splicing in the human genome
Changwei Shao et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
MBNL proteins and their target RNAs, interaction and splicing regulation
Patryk Konieczny et al.
NUCLEIC ACIDS RESEARCH (2014)
SR Proteins Collaborate with 7SK and Promoter-Associated Nascent RNA to Release Paused Polymerase
Xiong Ji et al.
CELL (2013)
EGFR Mutation-Induced Alternative Splicing of Max Contributes to Growth of Glycolytic Tumors in Brain Cancer
Ivan Babic et al.
CELL METABOLISM (2013)
Phase I Pharmacokinetic and Pharmacodynamic Study of the First-in-Class Spliceosome Inhibitor E7107 in Patients with Advanced Solid Tumors
Ferry A. L. M. Eskens et al.
CLINICAL CANCER RESEARCH (2013)
Protein Arginine Methyltransferase 5 (PRMT5) Inhibition Induces Lymphoma Cell Death through Reactivation of the Retinoblastoma Tumor Suppressor Pathway and Polycomb Repressor Complex 2 (PRC2) Silencing
Jihyun Chung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders
Tomoya Muto et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence
Y. Tang et al.
ONCOGENE (2013)
S6K1 Alternative Splicing Modulates Its Oncogenic Activity and Regulates mTORC1
Vered Ben-Hur et al.
CELL REPORTS (2013)
A syn-anti conformational difference allows SRSF2 to recognize guanines and cytosines equally well
Gerrit M. Daubner et al.
EMBO JOURNAL (2012)
SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance
Rong Jia et al.
International Journal of Biological Sciences (2012)
Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes
Rafael Bejar et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts
V. Visconte et al.
LEUKEMIA (2012)
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
Victor Quesada et al.
NATURE GENETICS (2012)
The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation
Olga Anczukow et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
The importance of CELF control: molecular and biological roles of the CUG-BP, Elav-like family of RNA-binding proteins
Twishasri Dasgupta et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2012)
A conserved role for intragenic DNA methylation in alternative pre-mRNA splicing
Shalini Oberdoerffer
TRANSCRIPTION-AUSTIN (2012)
c-Myc Regulates RNA Splicing of the A-Raf Kinase and Its Activation of the ERK Pathway
Jens Rauch et al.
CANCER RESEARCH (2011)
Protein Arginine Methyltransferase 5 Accelerates Tumor Growth by Arginine Methylation of the Tumor Suppressor Programmed Cell Death 4
Matthew A. Powers et al.
CANCER RESEARCH (2011)
Regulation of alternative splicing by the core spliceosomal machinery
Arneet L. Saltzman et al.
GENES & DEVELOPMENT (2011)
Global impact of RNA polymerase II elongation inhibition on alternative splicing regulation
Joanna Y. Ip et al.
GENOME RESEARCH (2011)
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
Sebahattin Cirak et al.
LANCET (2011)
CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing
Sanjeev Shukla et al.
NATURE (2011)
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
Poulikos I. Poulikakos et al.
NATURE (2011)
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
E. Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
Lili Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Histone Deacetylase Activity Modulates Alternative Splicing
Jarmila Hnilicova et al.
PLOS ONE (2011)
Antitumorigenic potential of STAT3 alternative splicing modulation
Francesca Zammarchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
An EMT-Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype
Irina M. Shapiro et al.
PLOS GENETICS (2011)
Identification of an Exon 4-Deletion Variant of Epidermal Growth Factor Receptor with Increased Metastasis-Promoting Capacity
Hai Wang et al.
NEOPLASIA (2011)
The U2AF35-related protein Urp contacts the 3′ splice site to promote U12-type intron splicing and the second step of U2-type intron splicing
Haihong Shen et al.
GENES & DEVELOPMENT (2010)
Global Analysis of Nascent RNA Reveals Transcriptional Pausing in Terminal Exons
Fernando Carrillo Oesterreich et al.
MOLECULAR CELL (2010)
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
Charles J. David et al.
NATURE (2010)
Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
Gorica Nikoloski et al.
NATURE GENETICS (2010)
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Thomas Ernst et al.
NATURE GENETICS (2010)
Position-dependent alternative splicing activity revealed by global profiling of alternative splicing events regulated by PTB
Miriam Llorian et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism
Cynthia V. Clower et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Regulation of Alternative Splicing by Histone Modifications
Reini F. Luco et al.
SCIENCE (2010)
The SR protein family of splicing factors: master regulators of gene expression
Jennifer C. Long et al.
BIOCHEMICAL JOURNAL (2009)
mTORβ Splicing Isoform Promotes Cell Proliferation and Tumorigenesis
Ganna Panasyuk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Aberrant BRAF splicing as an alternative mechanism for oncogenic B-Raf activation in thyroid carcinoma
Essa Y. Baitei et al.
JOURNAL OF PATHOLOGY (2009)
A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome
Keisuke Nimura et al.
NATURE (2009)
Differential chromatin marking of introns and expressed exons by H3K36me3
Paulina Kolasinska-Zwierz et al.
NATURE GENETICS (2009)
Neuronal cell depolarization induces intragenic chromatin modifications affecting NCAM alternative splicing
Ignacio E. Schor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing
Zhenxi Zhang et al.
CELL (2008)
The splicing factor SC35 has an active role in transcriptional elongation
Shengrong Lin et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation
John W. Edmunds et al.
EMBO JOURNAL (2008)
Recognition of trimethylated histone h3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing
Robert J. Sims et al.
MOLECULAR CELL (2007)
Two distinct arginine methyltransferases are required for biogenesis of Sm-class ribonucleoproteins
Graydon B. Gonsalvez et al.
JOURNAL OF CELL BIOLOGY (2007)
Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma
Sharmistha Pal et al.
EMBO JOURNAL (2007)
The gene encoding the splicing factor SF2/ASF is a proto-oncogene
Rotem Karni et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
An RNA map predicting Nova-dependent splicing regulation
Jernej Ule et al.
NATURE (2006)
Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer
S Agrawal et al.
HUMAN MOLECULAR GENETICS (2006)
Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes
S Pal et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Influence of polymerase II processivity on alternative splicing depends on splice site strength
G Nogués et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Pre-mRNA splicing: Awash in a sea of proteins
MS Jurica et al.
MOLECULAR CELL (2003)
Transcriptional activators differ in their abilities to control alternative splicing
G Nogués et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Methylation of Sm proteins by a complex containing PRMT5 and the putative U snRNP assembly factor pICln
G Meister et al.
CURRENT BIOLOGY (2001)
The methylosome, a 20S complex containing JBP1 and pICln, produces dimethylarginine-modified Sm proteins
WJ Friesen et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Antagonistic effects of T-Ag and VP16 reveal a role for RNA pol II elongation on alternative splicing
S Kadener et al.
EMBO JOURNAL (2001)
Share Paper
